
Uropath LLC, a provider of group practice-owned urologic pathology laboratories, has received positive results from audits conducted by the Department of Health and Human Services’ Office of Inspector General.

Uropath LLC, a provider of group practice-owned urologic pathology laboratories, has received positive results from audits conducted by the Department of Health and Human Services’ Office of Inspector General.

A combination of interferon alfa-2b and sorafenib (Nexavar) works better than does either drug alone in improving response in patients with renal cell carcinoma, according to a pilot study led by researchers from the Duke Comprehensive Cancer Center, Durham, NC.

Urology ranks fifth among specialties in terms of salary, with an average annual salary of $380,000 and a median of $325,520, according to a new survey from Martin, Fletcher, a national health care recruiting and consultancy firm.

The National Comprehensive Cancer Network has made updates to its kidney cancer guidelines to include the addition of two first-line treatment options.

The FDA has approved trospium chloride extended-release capsules (Sanctura XL) for once-daily treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.

Once you discover microscopic hematuria, typically the next step is evaluation with a careful history and physical exam, then specific laboratory tests, and cystoscopic and radiologic studies.

Presentations in pediatric urology at the 2007 AUA annual meeting signaled changes in practice, increasing momentum in current trends, and some surprising findings on hot-button topics.

The latest urology products and services.

Urologists attending this year's AUA annual meeting benefited from a wealth of cutting-edge research on the diagnosis and treatment of male infertility.

Studies of urinary tract infection presented at the 2007 AUA annual meeting had important lessons for practicing urologists.

Developments in laparoscopy, robotics, and other minimally invasive urologic techniques continue to evolve at a rapid pace.

While urologists continue to search for the most effective means of treating BPH and lower urinary tract symptoms, research presented at the 2007 AUA annual meeting suggests that drugs they may already be prescribing for other conditions could provide a novel solution.

The array of devices and procedures available to treat urinary incontinence and bladder dysfunction appears to be growing nonstop.

The AUA take-home messages on management of advanced prostate cancer underscore research interest in better defining the risks and benefits of androgen deprivation therapy (ADT) and provide some encouragement that new methods for treatment and evaluation will be available in the future to fill important gaps.

Among the studies presented at this year's AUA annual meeting, Glenn M. Preminger, MD, considered these to be among the most noteworthy presentations in the field of nephrolithiasis.

While it does not affect the vast majority of male infertility patients, a subgroup of men with disrupted hormonal axes and/or hypogonadism should be worked up for the presence of osteopenia.

The AUA take-home messages on management of localized prostate cancer.

In the area of sexual dysfunction, tomorrow arrived a little earlier than many attendees of the AUA annual meeting may have anticipated.

Patients with apparent interstitial cystitis need thorough workups, and they're not always getting them.

Prostate cancer patients treated by highly experienced surgeons are much more likely to be cancer-free 5 years after surgery than patients treated by surgeons with less experience, according to a study to be published in the Journal of the National Cancer Institute.

Based on the relative risk to siblings, 80% of kidney cancer cases are likely to occur in 20% of the population with the highest genetic risk, indicating the importance of further investigation of genetic factors in cancer prevention, according to a European multicenter, case-control study.

High intake of cruciferous vegetables, including broccoli and cauliflower, may be associated with reduced risk of aggressive prostate cancer, particularly extraprostatic disease, suggests a study to be published in the Journal of the National Cancer Institute.

Two urologists have been appointed to new positions at the University of Kentucky College of Medicine, Lexington. Stephen Strup, MD, has been appointed as chief of the division of urology, and Randall Rowland, MD, as CEO and president of the The Markey Cancer Foundation.

LocumTenens.com, a full-service physician/certified registered nurse anesthetists recruiting firm, has added urology to the list of surgical subspecialties staffed by the firm's surgery division.

Postoperative bleeding is a troublesome complication that can occur following virtually any type of urologic procedure. Prevention is the ideal treatment whenever possible. However, given the complexity and learning curve of many procedures, bleeding complications can and do occur.

Results of a retrospective, inter-institutional study comparing outcomes of patients with urothelial carcinoma of the bladder highly favor the use of an extended template for bilateral pelvic lymph node dissection (PLND) when performing radical cystectomy.

The primary message from a study evaluating long-term urothelial recurrence and disease-specific survival after radical nephroureterectomy for upper tract transitional cell carcinoma is that there remains a critical need for better methods to enable early diagnosis.

Patients with a relatively small volume of low-grade upper tract transitional cell carcinoma can be managed by purely endoscopic means over a long period of time.

A two-step transurethral resection (TURB) procedure in patients with superficial transitional bladder cancer, already part of practice guidelines in Germany, appears to improve patient outcomes by identifying positive tumor beds that may require a second TURB.

It may be time to update treatment guidelines for transitional cell carcinoma.